Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 66 entries
Sorted by: Best Match Show Resources per page
Nosocomial infections: new issues and strategies for prevention.

Infectious disease clinics of North America

[No authors listed]
PMID: 2592761
Infect Dis Clin North Am. 1989 Dec;3(4):671-929.

No abstract available.

Cite
Nosocomial infections: new issues and strategies for prevention. Infect Dis Clin North Am. 1989;3(4):671-929
(1989). Nosocomial infections: new issues and strategies for prevention. Infectious disease clinics of North America, 3(4), 671-929.
"Nosocomial infections: new issues and strategies for prevention." Infectious disease clinics of North America vol. 3,4 (1989): 671-929.
Nosocomial infections: new issues and strategies for prevention. Infect Dis Clin North Am. 1989 Dec;3(4):671-929. PMID: 2592761.
Copy Download .nbib Format: NLM
The ten commandments of caring for HIV-infected patients.

Infectious disease clinics of North America

Glatt AE.
PMID: 8089460
Infect Dis Clin North Am. 1994 Jun;8(2):275-8.

No practitioner can hide from HIV. Patients infected with HIV are treated in every type of practice setting as the number of cases increases at an alarming rate. This article provides 10 basic guidelines for the care of HIV-infected...

Cite
Glatt AE. The ten commandments of caring for HIV-infected patients. Infect Dis Clin North Am. 1994;8(2):275-8
Glatt, A. E. (1994). The ten commandments of caring for HIV-infected patients. Infectious disease clinics of North America, 8(2), 275-8.
Glatt, A E. "The ten commandments of caring for HIV-infected patients." Infectious disease clinics of North America vol. 8,2 (1994): 275-8.
Glatt AE. The ten commandments of caring for HIV-infected patients. Infect Dis Clin North Am. 1994 Jun;8(2):275-8. PMID: 8089460.
Copy Download .nbib Format: NLM
The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma.

Infectious disease clinics of North America

Hayashi PH, Di Bisceglie AM.
PMID: 16527646
Infect Dis Clin North Am. 2006 Mar;20(1):1-25. doi: 10.1016/j.idc.2006.01.003.

Much information has been gained in the diagnosis and treatment of HCC during the last 15 years. Ever improving imaging technology has made nonhistologic diagnostic criteria possible, albeit controversial. Liver transplantation, resection, and RFA are considered curative options. Yet,HCC...

Cite
Hayashi PH, Di Bisceglie AM. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma. Infect Dis Clin North Am. 2006;20(1):1-25doi: 10.1016/j.idc.2006.01.003.
Hayashi, P. H., & Di Bisceglie, A. M. (2006). The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma. Infectious disease clinics of North America, 20(1), 1-25. https://doi.org/10.1016/j.idc.2006.01.003
Hayashi, Paul H, and Di Bisceglie, Adrian M. "The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma." Infectious disease clinics of North America vol. 20,1 (2006): 1-25. doi: https://doi.org/10.1016/j.idc.2006.01.003
Hayashi PH, Di Bisceglie AM. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma. Infect Dis Clin North Am. 2006 Mar;20(1):1-25. doi: 10.1016/j.idc.2006.01.003. PMID: 16527646.
Copy Download .nbib Format: NLM
Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic response.

Infectious disease clinics of North America

Sethi A, Shiffman ML.
PMID: 16527652
Infect Dis Clin North Am. 2006 Mar;20(1):115-35. doi: 10.1016/j.idc.2006.01.002.

The combination of PEGIFN and RBV is the most effective therapy for patients with chronic hepatitis C. Although more than half of all patients are able to achieve SVR, a significant proportion of patients, particularly those with genotype 1,...

Cite
Sethi A, Shiffman ML. Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic response. Infect Dis Clin North Am. 2006;20(1):115-35doi: 10.1016/j.idc.2006.01.002.
Sethi, A., & Shiffman, M. L. (2006). Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic response. Infectious disease clinics of North America, 20(1), 115-35. https://doi.org/10.1016/j.idc.2006.01.002
Sethi, Amrita, and Shiffman, Mitchell L. "Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic response." Infectious disease clinics of North America vol. 20,1 (2006): 115-35. doi: https://doi.org/10.1016/j.idc.2006.01.002
Sethi A, Shiffman ML. Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic response. Infect Dis Clin North Am. 2006 Mar;20(1):115-35. doi: 10.1016/j.idc.2006.01.002. PMID: 16527652.
Copy Download .nbib Format: NLM
Management of recurrent hepatitis C in liver transplant recipients.

Infectious disease clinics of North America

Biggins SW, Terrault NA.
PMID: 16527654
Infect Dis Clin North Am. 2006 Mar;20(1):155-74. doi: 10.1016/j.idc.2006.01.011.

Recurrent HCV infection is universal in liver transplant recipients who are viremic pretransplant. The rate of histologic disease progression after transplantation is more rapid, and the risk of cirrhosis by 5 to 10 years is about 30%. Several donor,...

Cite
Biggins SW, Terrault NA. Management of recurrent hepatitis C in liver transplant recipients. Infect Dis Clin North Am. 2006;20(1):155-74doi: 10.1016/j.idc.2006.01.011.
Biggins, S. W., & Terrault, N. A. (2006). Management of recurrent hepatitis C in liver transplant recipients. Infectious disease clinics of North America, 20(1), 155-74. https://doi.org/10.1016/j.idc.2006.01.011
Biggins, Scott W, and Terrault, Norah A. "Management of recurrent hepatitis C in liver transplant recipients." Infectious disease clinics of North America vol. 20,1 (2006): 155-74. doi: https://doi.org/10.1016/j.idc.2006.01.011
Biggins SW, Terrault NA. Management of recurrent hepatitis C in liver transplant recipients. Infect Dis Clin North Am. 2006 Mar;20(1):155-74. doi: 10.1016/j.idc.2006.01.011. PMID: 16527654.
Copy Download .nbib Format: NLM
Severe acute respiratory syndrome (SARS).

Infectious disease clinics of North America

Cleri DJ, Ricketti AJ, Vernaleo JR.
PMID: 20171552
Infect Dis Clin North Am. 2010 Mar;24(1):175-202. doi: 10.1016/j.idc.2009.10.005.

This article reviews the virology, history, pathology, epidemiology, clinical presentations, complications, radiology, laboratory testing, diagnosis, treatment, and prevention of severe respiratory distress syndrome, with reference to documented outbreaks of the disease.

Cite
Cleri DJ, Ricketti AJ, Vernaleo JR. Severe acute respiratory syndrome (SARS). Infect Dis Clin North Am. 2010;24(1):175-202doi: 10.1016/j.idc.2009.10.005.
Cleri, D. J., Ricketti, A. J., & Vernaleo, J. R. (2010). Severe acute respiratory syndrome (SARS). Infectious disease clinics of North America, 24(1), 175-202. https://doi.org/10.1016/j.idc.2009.10.005
Cleri, Dennis J, et al. "Severe acute respiratory syndrome (SARS)." Infectious disease clinics of North America vol. 24,1 (2010): 175-202. doi: https://doi.org/10.1016/j.idc.2009.10.005
Cleri DJ, Ricketti AJ, Vernaleo JR. Severe acute respiratory syndrome (SARS). Infect Dis Clin North Am. 2010 Mar;24(1):175-202. doi: 10.1016/j.idc.2009.10.005. PMID: 20171552; PMCID: PMC7135483.
Copy Download .nbib Format: NLM
Staphylococcal vaccines and immunotherapies.

Infectious disease clinics of North America

Schaffer AC, Lee JC.
PMID: 19135920
Infect Dis Clin North Am. 2009 Mar;23(1):153-71. doi: 10.1016/j.idc.2008.10.005.

Staphylococcus aureus is an important pathogen in the hospital and in the community, and it is increasingly resistant to multiple antibiotics. A nonantimicrobial approach to controlling S aureus is needed. The most extensively tested vaccine against S aureus, which...

Cite
Schaffer AC, Lee JC. Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am. 2009;23(1):153-71doi: 10.1016/j.idc.2008.10.005.
Schaffer, A. C., & Lee, J. C. (2009). Staphylococcal vaccines and immunotherapies. Infectious disease clinics of North America, 23(1), 153-71. https://doi.org/10.1016/j.idc.2008.10.005
Schaffer, Adam C, and Lee, Jean C. "Staphylococcal vaccines and immunotherapies." Infectious disease clinics of North America vol. 23,1 (2009): 153-71. doi: https://doi.org/10.1016/j.idc.2008.10.005
Schaffer AC, Lee JC. Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am. 2009 Mar;23(1):153-71. doi: 10.1016/j.idc.2008.10.005. PMID: 19135920.
Copy Download .nbib Format: NLM
Global health capacity and workforce development: turning the world upside down.

Infectious disease clinics of North America

Crisp N.
PMID: 21628051
Infect Dis Clin North Am. 2011 Jun;25(2):359-67. doi: 10.1016/j.idc.2011.02.010.

This article explores global health and the way in which the whole world is increasingly interdependent in terms of health. High-income countries need to help redress the balance of power and resources around the world, for self interest and...

Cite
Crisp N. Global health capacity and workforce development: turning the world upside down. Infect Dis Clin North Am. 2011;25(2):359-67doi: 10.1016/j.idc.2011.02.010.
Crisp, N. (2011). Global health capacity and workforce development: turning the world upside down. Infectious disease clinics of North America, 25(2), 359-67. https://doi.org/10.1016/j.idc.2011.02.010
Crisp, Nigel. "Global health capacity and workforce development: turning the world upside down." Infectious disease clinics of North America vol. 25,2 (2011): 359-67. doi: https://doi.org/10.1016/j.idc.2011.02.010
Crisp N. Global health capacity and workforce development: turning the world upside down. Infect Dis Clin North Am. 2011 Jun;25(2):359-67. doi: 10.1016/j.idc.2011.02.010. PMID: 21628051; PMCID: PMC7127544.
Copy Download .nbib Format: NLM
On the Interface of Infectious Diseases and Critical Care Medicine.

Infectious disease clinics of North America

O'Grady NP, Kadri SS.
PMID: 28779835
Infect Dis Clin North Am. 2017 Sep;31(3):xiii-xiv. doi: 10.1016/j.idc.2017.07.001.

No abstract available.

Cite
O'Grady NP, Kadri SS. On the Interface of Infectious Diseases and Critical Care Medicine. Infect Dis Clin North Am. 2017;31(3):xiii-xivdoi: 10.1016/j.idc.2017.07.001.
O'Grady, N. P., & Kadri, S. S. (2017). On the Interface of Infectious Diseases and Critical Care Medicine. Infectious disease clinics of North America, 31(3), xiii-xiv. https://doi.org/10.1016/j.idc.2017.07.001
O'Grady, Naomi P, and Kadri, Sameer S. "On the Interface of Infectious Diseases and Critical Care Medicine." Infectious disease clinics of North America vol. 31,3 (2017): xiii-xiv. doi: https://doi.org/10.1016/j.idc.2017.07.001
O'Grady NP, Kadri SS. On the Interface of Infectious Diseases and Critical Care Medicine. Infect Dis Clin North Am. 2017 Sep;31(3):xiii-xiv. doi: 10.1016/j.idc.2017.07.001. PMID: 28779835; PMCID: PMC7125617.
Copy Download .nbib Format: NLM
Disinfection and Sterilization in Health Care Facilities: An Overview and Current Issues.

Infectious disease clinics of North America

Rutala WA, Weber DJ.
PMID: 34362535
Infect Dis Clin North Am. 2021 Sep;35(3):575-607. doi: 10.1016/j.idc.2021.04.004.

All invasive procedures involve contact by a medical device or surgical instrument with a patient's sterile tissue or mucous membranes. The level of disinfection is dependent on the intended use of the object: critical, semicritical, or noncritical. New issues...

Cite
Rutala WA, Weber DJ. Disinfection and Sterilization in Health Care Facilities: An Overview and Current Issues. Infect Dis Clin North Am. 2021;35(3):575-607doi: 10.1016/j.idc.2021.04.004.
Rutala, W. A., & Weber, D. J. (2021). Disinfection and Sterilization in Health Care Facilities: An Overview and Current Issues. Infectious disease clinics of North America, 35(3), 575-607. https://doi.org/10.1016/j.idc.2021.04.004
Rutala, William A, and Weber, David J. "Disinfection and Sterilization in Health Care Facilities: An Overview and Current Issues." Infectious disease clinics of North America vol. 35,3 (2021): 575-607. doi: https://doi.org/10.1016/j.idc.2021.04.004
Rutala WA, Weber DJ. Disinfection and Sterilization in Health Care Facilities: An Overview and Current Issues. Infect Dis Clin North Am. 2021 Sep;35(3):575-607. doi: 10.1016/j.idc.2021.04.004. PMID: 34362535.
Copy Download .nbib Format: NLM
Surgical Site Infections.

Infectious disease clinics of North America

Seidelman J, Anderson DJ.
PMID: 34752225
Infect Dis Clin North Am. 2021 Dec;35(4):901-929. doi: 10.1016/j.idc.2021.07.006.

Surgical site infections (SSIs) are among the most common and most costly health care-associated infections, leading to adverse patient outcomes and death. Wound contamination occurs with each incision, but proven strategies exist to decrease the risk of SSI. In...

Cite
Seidelman J, Anderson DJ. Surgical Site Infections. Infect Dis Clin North Am. 2021;35(4):901-929doi: 10.1016/j.idc.2021.07.006.
Seidelman, J., & Anderson, D. J. (2021). Surgical Site Infections. Infectious disease clinics of North America, 35(4), 901-929. https://doi.org/10.1016/j.idc.2021.07.006
Seidelman, Jessica, and Anderson, Deverick J. "Surgical Site Infections." Infectious disease clinics of North America vol. 35,4 (2021): 901-929. doi: https://doi.org/10.1016/j.idc.2021.07.006
Seidelman J, Anderson DJ. Surgical Site Infections. Infect Dis Clin North Am. 2021 Dec;35(4):901-929. doi: 10.1016/j.idc.2021.07.006. PMID: 34752225.
Copy Download .nbib Format: NLM
Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide.

Infectious disease clinics of North America

Wood BR.
PMID: 31255385
Infect Dis Clin North Am. 2019 Sep;33(3):693-705. doi: 10.1016/j.idc.2019.04.003. Epub 2019 Jun 27.

This review provides a synopsis of key clinical considerations for switching antiretroviral therapy (ART) for individuals with human immunodeficiency virus who have maintained a routinely suppressed viral load. There may be benefits but also risks involved in every ART...

Cite
Wood BR. Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide. Infect Dis Clin North Am. 2019;33(3):693-705doi: 10.1016/j.idc.2019.04.003.
Wood, B. R. (2019). Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide. Infectious disease clinics of North America, 33(3), 693-705. https://doi.org/10.1016/j.idc.2019.04.003
Wood, Brian R. "Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide." Infectious disease clinics of North America vol. 33,3 (2019): 693-705. doi: https://doi.org/10.1016/j.idc.2019.04.003
Wood BR. Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide. Infect Dis Clin North Am. 2019 Sep;33(3):693-705. doi: 10.1016/j.idc.2019.04.003. Epub 2019 Jun 27. PMID: 31255385.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 66 entries